Description
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from 8th May 2026 to 14th May 2026, with an offer price of Rs. 250 per share for up to 16,00,000 equity shares.
Summary
BSE has announced the live activities schedule for the Offer to Buy (OTB) – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Ltd (Symbol: JAGSNPHARM, Scrip Code: 507789, ISIN: INE048B01035). The buyback window opens on Friday, 8th May 2026 and closes on Thursday, 14th May 2026. The offer is for up to 16,00,000 equity shares at a price of Rs. 250.00 per share.
Key Points
- Security: Jagsonpal Pharmaceuticals Ltd | Symbol: JAGSNPHARM | ISIN: INE048B01035 | Scrip Code: 507789
- Offer Size: Up to 16,00,000 Equity Shares
- Offer Price: Rs. 250.00 per share
- Face Value: Rs. 2.00
- Market Lot: 1
- Opening Date: Friday, 8th May 2026
- Closing Date: Thursday, 14th May 2026
- Session Timings: 9:15 a.m. to 3:30 p.m. for most activities; Take-up on the last day extended to 4:00 p.m.
- Bids can only be placed for investors holding shares in demat form
- Trading Members must ensure UCC of investors is registered with correct PAN and Category
Regulatory Changes
No new regulatory changes introduced. This notice operationalises the existing OTB framework as per Exchange Notices 20150930-1 (dated 30 September 2015) and 20170203-29 (dated 3 February 2017).
Compliance Requirements
- Trading Members must ensure the Unique Client Code (UCC) of each investor is registered and updated with the correct PAN Number and Category in the Exchange UCC database before placing bids.
- Members and Custodians should note that if no securities are accepted, no End of Issue files will be generated on the Extranet.
- Participants must use the designated iBBS and RTRMS platforms for bid submission and modifications.
- For leased line access settings, refer to Exchange Circular No. 20170503-12.
Important Dates
| Activity | Period | Timings |
|---|---|---|
| Bid Offering Period | 8th May 2026 – 14th May 2026 | 9:15 a.m. – 3:30 p.m. |
| Bid Modifications / Cancellation | 8th May 2026 – 14th May 2026 | 9:15 a.m. – 3:30 p.m. |
| Give-up / Take-up | 8th May 2026 – 13th May 2026 | 9:15 a.m. – 3:30 p.m. |
| Give-up (last day) | 14th May 2026 | 9:15 a.m. – 3:30 p.m. |
| Take-up (last day) | 14th May 2026 | 9:15 a.m. – 4:00 p.m. |
Impact Assessment
This circular is operationally relevant to Trading Members and Custodian Members participating in the Jagsonpal Pharmaceuticals buyback. The offer is open to multiple investor categories including FIIs, FIs, Mutual Funds, Insurance Companies, other QIBs, NIBs, companies, and individual investors. The impact is limited to participants in this specific buyback and does not affect broader market operations. Members should prepare their systems and ensure UCC compliance before 8th May 2026.
Impact Justification
Company-specific buyback notice relevant to investors and trading members of Jagsonpal Pharmaceuticals Ltd; operational in nature with defined schedule and procedures for participation.